Patricia Marañón

TITLE: Bone morphogenetic protein 2 is a new molecular target linked to nonalcoholic fatty liver disease with potential value as non-invasive screening tool. Running Title: BMP2 is linked to NAFLD. AUTHORS:

Stephania C. Isaza, R. Gallego-Durán, C. Fernández-García, 2022 .

Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool

Á. González-Rodríguez, J. Ampuero, M. Romero-Gómez, 2022, medRxiv.

Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function.

D. Serra, M. Schwaninger, M. Martínez-Chantar, 2021, Journal of hepatology.

Insulin receptor substrate 2 (IRS2) deficiency delays liver fibrosis associated with cholestatic injury

P. Rada, Á. Valverde, Á. González-Rodríguez, 2019, Disease Models & Mechanisms.

Angiopoietin-Like Protein 8 Is a Novel Vitamin D Receptor Target Gene Involved in Nonalcoholic Fatty Liver Pathogenesis.

Á. González-Rodríguez, J. Castell, P. Petrov, 2018, The American journal of pathology.

Hypoxia‐inducible factor 2α drives hepatosteatosis through the fatty acid translocase CD36

Á. González-Rodríguez, J. Aragonés, C. García-Monzón, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Intrahepatic Expression of Fatty Acid Translocase CD36 Is Increased in Obstructive Sleep Apnea

R. Farré, I. Almendros, Á. González-Rodríguez, 2020, Frontiers in Medicine.

Inhibition of ALK3-mediated signalling pathway protects against acetaminophen-induced liver injury

P. Rada, Á. González-Rodríguez, Stephania C. Isaza, 2024, Redox biology.

Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis

Á. Valverde, Á. González-Rodríguez, J. Ampuero, 2023, Biomarker Research.